Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium | 1 | 2008 | 156 | 0.300 |
Why?
|
| Cell Communication | 1 | 2008 | 513 | 0.260 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 1501 | 0.220 |
Why?
|
| Endothelial Cells | 3 | 2013 | 1037 | 0.210 |
Why?
|
| Aortic Valve | 1 | 2024 | 448 | 0.190 |
Why?
|
| Cell Lineage | 2 | 2013 | 696 | 0.150 |
Why?
|
| Genes, Reporter | 2 | 2009 | 820 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2013 | 12097 | 0.130 |
Why?
|
| Stem Cells | 2 | 2013 | 1213 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2015 | 46 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2015 | 58 | 0.120 |
Why?
|
| Endothelium, Lymphatic | 1 | 2013 | 14 | 0.110 |
Why?
|
| Aldehyde Oxidoreductases | 2 | 2013 | 31 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 299 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 216 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 483 | 0.100 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 40 | 0.100 |
Why?
|
| Tretinoin | 2 | 2013 | 618 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 878 | 0.080 |
Why?
|
| Genetic Techniques | 1 | 2009 | 151 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2013 | 4120 | 0.070 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2007 | 32 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 1371 | 0.070 |
Why?
|
| Heterozygote | 1 | 2008 | 1053 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2008 | 604 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 1557 | 0.060 |
Why?
|
| Time Factors | 2 | 2024 | 12993 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2161 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2008 | 3045 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 3213 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 4222 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 345 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2024 | 349 | 0.040 |
Why?
|
| Models, Biological | 1 | 2008 | 3195 | 0.040 |
Why?
|
| Reoperation | 1 | 2024 | 1391 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 9038 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 3341 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1233 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4803 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 4649 | 0.040 |
Why?
|
| Animals | 5 | 2015 | 61965 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2024 | 1159 | 0.030 |
Why?
|
| Mice | 3 | 2015 | 35547 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 563 | 0.030 |
Why?
|
| Embryo Culture Techniques | 1 | 2013 | 31 | 0.030 |
Why?
|
| Lac Operon | 1 | 2013 | 133 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2013 | 50 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 164 | 0.030 |
Why?
|
| Lymphangiogenesis | 1 | 2013 | 44 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2013 | 213 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 272 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8612 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1376 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 101 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 278 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 2420 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2024 | 5673 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2013 | 7237 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13939 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 307 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 339 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 5758 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 17826 | 0.020 |
Why?
|
| United States | 1 | 2024 | 15823 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2007 | 320 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 345 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 2195 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 936 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 1497 | 0.010 |
Why?
|
| Male | 3 | 2024 | 127960 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 5716 | 0.010 |
Why?
|
| Humans | 6 | 2024 | 270200 | 0.010 |
Why?
|
| Transfection | 1 | 2009 | 3118 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 1857 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 1586 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2009 | 2137 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2024 | 33694 | 0.010 |
Why?
|
| Female | 3 | 2024 | 148466 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12513 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 5339 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 39688 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 3639 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 8082 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 5433 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 5435 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 6179 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 14622 | 0.010 |
Why?
|